William Blair & Company’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.75M Buy
330,007
+21,442
+7% +$568K 0.02% 375
2025
Q1
$7.45M Buy
308,565
+36,696
+13% +$886K 0.02% 388
2024
Q4
$10.9M Buy
271,869
+44,915
+20% +$1.81M 0.03% 323
2024
Q3
$14.4M Buy
226,954
+125,747
+124% +$7.96M 0.04% 290
2024
Q2
$5.36M Sell
101,207
-198,028
-66% -$10.5M 0.02% 470
2024
Q1
$24.5M Buy
299,235
+240,863
+413% +$19.8M 0.08% 187
2023
Q4
$1.09M Sell
58,372
-32,173
-36% -$599K ﹤0.01% 830
2023
Q3
$1M Sell
90,545
-26,334
-23% -$292K ﹤0.01% 833
2023
Q2
$1.89M Buy
116,879
+8,934
+8% +$145K 0.01% 678
2023
Q1
$1.8M Buy
107,945
+74,788
+226% +$1.25M 0.01% 680
2022
Q4
$312K Sell
33,157
-80,631
-71% -$758K ﹤0.01% 1213
2022
Q3
$310K Sell
113,788
-45,130
-28% -$123K ﹤0.01% 1216
2022
Q2
$459K Sell
158,918
-799
-0.5% -$2.31K ﹤0.01% 1095
2022
Q1
$479K Buy
159,717
+6,454
+4% +$19.4K ﹤0.01% 1170
2021
Q4
$705K Buy
153,263
+8,082
+6% +$37.2K ﹤0.01% 1082
2021
Q3
$912K Sell
145,181
-11,555
-7% -$72.6K ﹤0.01% 966
2021
Q2
$939K Buy
156,736
+3,000
+2% +$18K ﹤0.01% 940
2021
Q1
$972K Buy
153,736
+6,910
+5% +$43.7K ﹤0.01% 908
2020
Q4
$827K Buy
146,826
+37,425
+34% +$211K ﹤0.01% 923
2020
Q3
$637K Buy
109,401
+36,335
+50% +$212K ﹤0.01% 902
2020
Q2
$527K Sell
73,066
-1,500
-2% -$10.8K ﹤0.01% 926
2020
Q1
$349K Sell
74,566
-15,255
-17% -$71.4K ﹤0.01% 972
2019
Q4
$720K Sell
89,821
-60,487
-40% -$485K ﹤0.01% 870
2019
Q3
$1.03M Sell
150,308
-8,150
-5% -$56.1K 0.01% 737
2019
Q2
$1.32M Sell
158,458
-4,825
-3% -$40K 0.01% 691
2019
Q1
$1.62M Buy
163,283
+1,453
+0.9% +$14.4K 0.01% 616
2018
Q4
$1.24M Buy
161,830
+156,330
+2,842% +$1.2M 0.01% 633
2018
Q3
$96K Buy
5,500
+500
+10% +$8.73K ﹤0.01% 1377
2018
Q2
$47K Buy
+5,000
New +$47K ﹤0.01% 1419